Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Brain Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 14Carcinoma, Hepatocellular 11Lung Neoplasms 10Prostatic Neoplasms 9Breast Neoplasms 5Neoplasms 4Melanoma 3Carcinoma, Renal Cell 3Small Cell Lung Carcinoma 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Stage II Prostate Adenocarcinoma AJCC v7 1Sarcoma, Ewing 1Radiation Therapy 1Radiation Injuries 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer Metastatic 1Pituitary Neoplasms 1Patients Receiving Fractionated Stereotactic Radiotherapy 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Oligometastatic Hormone Sensitive Prostate Cancer 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Nasopharyngeal Carcinoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1

Interventions

Vincristine 2Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Busulfan 2treosulfan 1ganitumab 1etoposide phosphate 1Zoledronic Acid 1Triptorelin Pamoate 1Temozolomide 1Radiosurgery 1Radiation 1Melphalan 1Irinotecan 1FANG vaccine 1Diphosphonates 1Dactinomycin 1Cyproheptadine 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma, Ewing × Radiosurgery × Clear all
NCT02306161 2026-05-27

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡